Search Tag: lung cancer
2024 19 Jun
Radiomics is a method that extracts detailed data, known as radiomic features, from medical images like CT and MRI. These features can reveal tissue characteristics at a microscopic level, potentially serving as biomarkers in oncology. They offer a non-invasive way to assess entire tumours and track changes over time. Radiomic features include...Read more
2024 29 May
Lung cancer remains the foremost cause of cancer-related mortality globally, with a disheartening overall 5-year relative survival rate of just 22.9%. However, the prognosis improves significantly when lung cancer is detected early. Patients diagnosed with localized lung cancer have a 5-year survival rate of 61.2%, in stark contrast to the 7% for...Read more
2024 27 May
Deprivation, measured by the Index of Multiple Deprivation (IMD) in the UK, is linked to numerous health issues, including a higher risk of lung cancer. A significant disparity exists in smoking prevalence between socioeconomic groups, with 23.8% of those in the most deprived neighbourhoods being current smokers in 2021, compared to 6.8%...Read more
2024 16 May
Subsolid nodules, including pure ground-glass nodules (pGGNs) and part-solid nodules (PSNs), are increasingly detected through incidental findings or lung cancer screening. Despite their generally slow-growing nature, these nodules carry a high risk of malignancy. While some are transient inflammatory processes, persistent nodules are often associated...Read more
2024 09 Dec
<marquee behavior="slide" direction="left" scrollamount="30"> <h2 style="text-align: center;"><font color="#000099"><b>Find ESMO On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/myesmo target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><Read more
2024 26 Mar
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find ESMO On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/myesmo target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><Read more
2023 16 Nov
According to a large-scale study by Mount Sinai researchers, diagnosing early-stage lung cancer with low-dose CT screening improves the cure rate measured over a 20-year period. Since 1992, the effectiveness of low-dose CT screening for lung cancer has been studied and this led to the creation of the International Early Lung Cancer Action Programme...Read more
2023 11 Sep
A study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer revealed that key reproductive factors such as early menopause, shortened reproductive span, and early age at first birth are associated with elevated risks of lung cancer in women. Researchers from Xiangya Hospital, Changsha,...Read more
2023 23 Jun
Lung cancer is the leading cause of cancer death in the U.S. Early detection of lung cancer improves survival chances, but lung cancer screening rates are much lower than those of other cancer screening tests. Placing prompts in the electronic health record systems will help to remind primary care physicians of patients’ eligibility for lung...Read more
2023 08 Jun
Vaclav Potesil is the Chief Business Officer and Founder of Optellum, an Oxford-based company dedicated to transforming lung cancer treatment. Unfortunately, lung cancer is the most common type of cancer and the leading cause of cancer deaths in the world, claiming more lives than breast cancer and prostate cancer combined. However, with the rapid...Read more
2023 10 May
LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to welcome Leah Fine, MBA, as the vice president of its soon-to-be-launched Early Lung Cancer Center. LUNGevity takes a holistic approach to accelerate early detection and early disease management through research, public policy, health equity, and lung...Read more
2022 18 Nov
In a cohort study of 685 adults with a positive lung cancer screening examination, adherence to recommended care improved among those with a higher suspicion of lung cancer, as well as after extending the follow-up timeline. The study was published in JAMA Network. Recruited individuals were aged 18 years and over who underwent lung cancer...Read more
2022 27 Jan
Facilitating decisions using vast amounts of comparative data – AI can do this, but creating the algorithms is a complex and lengthy process. Yet it can make a difference, especially in lung cancer care. The lack of early symptoms and the aggressive progression of lung cancer make it one of the deadliest types of cancer.[1] Individually adapted...Read more
2021 21 Dec
Most physicians agree that discovering lung cancer early is critical to saving lives. Over 200,000 people receive lung cancer diagnoses annually and this remains a leading causes of U.S. cancer deaths. For the first time, a large retrospective population study, conducted by researchers at Icahn School of Medicine at Mount Sinai, demonstrated this. The study...Read more
2021 09 Nov
Researchers at Brigham and Women’s Hospital (Boston, MA) recently published a study in the Journal of the American College of Radiology showing that patient retention in a lung cancer screening (LCS) programme drops after diagnostic chest computed tomography (CT) examinations. Lung cancer is the leading cause of US cancer-related death, and screening...Read more
2021 14 Oct
Siemens Healthineers recently added non-small cell lung cancer support to its AI Pathway Companion. Currently supported pathways are non-small cell lung and prostate cancer. Siemens first presented its AI Pathway Companion at the 2018 Annual Meeting of the Radiological Society of North America in Chicago. In summary, the system delivers artificial...Read more
2021 10 Aug
New AI solution enables personalized decision making along the lung cancer pathway Facilitates patient management and case reviews by combining into a single dashboard Second pathway for AI-Pathway Companion after pathway for prostate cancer Siemens Healthineers presents its second pathway for its AI-Pathway Companion 1 at the...Read more
2021 18 Feb
A deep learning (DL) model developed at the Pennsylvania State University proved to be much more efficient in predicting survival expectancy of lung cancer patients than the traditional ML models (Doppalapudi et al. 2021). You might also like: Deep learning models are more efficient at discerning patterns and discriminative features...Read more
2019 04 Dec
Affidea and Aidence announce a strategic partnership to streamline and improve the clinical performance of lung diagnosis and screening to drive the earlier detection and treatment in the case of lung cancer. As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration with Aidence, a medical...Read more